BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 37239077)

  • 1. Paraneoplastic Neurological Syndromes of the Central Nervous System: Pathophysiology, Diagnosis, and Treatment.
    Marsili L; Marcucci S; LaPorta J; Chirra M; Espay AJ; Colosimo C
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic neurological syndromes.
    Honnorat J; Antoine JC
    Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
    Braik T; Evans AT; Telfer M; McDunn S
    Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paraneoplastic neurological syndromes].
    Didelot A; Honnorat J
    Rev Med Interne; 2011 Oct; 32(10):605-11. PubMed ID: 21036427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic neurological syndrome: an evolving story.
    Jitprapaikulsan J; Paul P; Thakolwiboon S; Mittal SO; Pittock SJ; Dubey D
    Neurooncol Pract; 2021 Aug; 8(4):362-374. PubMed ID: 34277016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
    Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
    Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
    Fu P; He L; Tang N; Nie Q; Li Z
    J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
    Blaes F
    Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
    [No Abstract]   [Full Text] [Related]  

  • 13. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
    Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM
    Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review.
    Li L; Guo Y; Wang J
    Ann Transl Med; 2023 Apr; 11(7):283. PubMed ID: 37090044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
    Yamamoto T; Tsuji S
    Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic disorders of the central and peripheral nervous systems.
    Didelot A; Honnorat J
    Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on neurological paraneoplastic syndromes.
    Höftberger R; Rosenfeld MR; Dalmau J
    Curr Opin Oncol; 2015 Nov; 27(6):489-95. PubMed ID: 26335665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome.
    Michalak S; Cofta S; Piatek A; Rybacka J; Wysocka E; Kozubski W
    Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):156-61. PubMed ID: 20156748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series.
    Giammello F; Galletta K; Grillo F; Brizzi T; Cavallaro M; Mormina E; Scelzo E; Allegra C; Stancanelli C; Rodolico C; Musumeci O; Toscano A; Granata F
    Acta Neurol Belg; 2023 Aug; 123(4):1355-1369. PubMed ID: 36884202
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.